Skip to main content
Clinical Trials/TCTR20230629003
TCTR20230629003
Not Yet Recruiting
N/A

Assessment of walking performance in individuals with and without peripheral artery disease

/A0 sites184 target enrollmentJune 29, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
reduced walking performance in individuals with peripheral artery disease
Sponsor
/A
Enrollment
184
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 29, 2023
End Date
November 30, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • 1\. Presence ABI \<\=0\.9 or TBI \<\=0\.7 in PAD group
  • 2\. Presence ABI \>0\.9 or TBI \>0\.7 in non\-PAD group
  • 3\. Presence PAD classification of asymptomatic PAD and symptomatic PAD (mild to severe claudication) according to Rutherford classification
  • \-Able to follow the instruction

Exclusion Criteria

  • 1\. Presence musculoskeletal conditions e.g., severe arthritis, osteoporosis, and acute fracture
  • 2\. Presence neurological disorders e.g., hemiplegia and Parkinson's disease
  • 3\. Presence unstable heart diseases
  • 4\. Presence respiratory diseases e.g., chronic obstructive pulmonary disease and asthma
  • \-Unable to walk independently or use walking aids

Outcomes

Primary Outcomes

Not specified

Similar Trials